Wessex competition searching for tech that can improve care for pregnant women

The second round of the Wessex Technology Support Programme has launched in search of innovation diagnostic and monitoring tools for reproductive women’s health.

The Wessex Technology Support Programme is looking for companies who are developing advanced tools to improve patient care for pregnant women.

The NHS spends around £560 million every year compensating families for negligence that occurs during maternity care.

It’s thought that the introduction of better diagnostic and monitoring tools could improve current maternity care and even predict or reduce complications at childbirth.

Current challenges include accurately stratifying high-risk women during the preconception and antenatal period, screening for prematurity, and predicting unexpected outcomes at birth. Other challenges are in finding aids for difficult delivery, timely diagnosis and management of preeclampsia, and the effective management of acute bleeding postpartum.

Digital tools could support clinical decision making, as well as reduce variability in clinical interpretation. Innovative ideas could include ways to collect and report the reproductive health status of the woman via point-of-care or a lab-on-chip device.

The Wessex Technology Support is seeking companies that are working in this area and have an innovation, not currently in use in the NHS, which they want to evaluate in an NHS setting.

Interested parties can apply here.



Reece Armstrong is a reporter for Digital Health Age. Coming from the North East of England, Reece has an MA in Media & Journalism and a BA in Popular & Contemporary Music from Newcastle University. Reach him on Twitter or email via: reece.armstrong@rapidnews.com


'Wessex competition searching for tech that can improve care for pregnant women' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions